ロード中...
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
BACKGROUND: Capecitabine, an orally administered fluoropyrimidines, is widely used in the treatment of multiple malignancies. It has been extensively evaluated in patients with gastroesophageal carcinoma. Since recent reviews have discussed phase I/II trials (Cancer 107:221–231, 2006; Drugs 67:601–6...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503649/ https://ncbi.nlm.nih.gov/pubmed/18728703 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|